Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults.
about
Nutrition and Hepatocellular CancerMitochondria, cholesterol and cancer cell metabolismHepatocellular carcinoma: From clinical practice to evidence-based treatment protocolsTargeting p110gamma in gastrointestinal cancers: attack on multiple frontsThe links between insulin resistance, diabetes, and cancerSimple sugar intake and hepatocellular carcinoma: epidemiological and mechanistic insightPatients with old age or proximal tumors benefit from metabolic syndrome in early stage gastric cancer.Characterization and prognosis of patients with hepatocellular carcinoma (HCC) in the non-cirrhotic liverIdentification of anticancer drugs for hepatocellular carcinoma through personalized genome-scale metabolic modeling.Genetic factors associated with risk of metabolic syndrome and hepatocellular carcinomaAnalysis of Preoperative Metabolic Risk Factors Affecting the Prognosis of Patients with Esophageal Squamous Cell Carcinoma: The Fujian Prospective Investigation of Cancer (FIESTA) Study.Total serum cholesterol and cancer incidence in the Metabolic syndrome and Cancer Project (Me-Can)Metabolic Syndrome Prevalence by Race/Ethnicity and Sex in the United States, National Health and Nutrition Examination Survey, 1988-2012.Effects of statins on the risk of hepatocellular carcinomaSerum glucose and risk of cancer: a meta-analysis.A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative study.Is hepatitis C virus carcinogenic?Metabolic serum biomarkers for the prediction of cancer: a follow-up of the studies conducted in the Swedish AMORIS studyMetabolic risk score and cancer risk: pooled analysis of seven cohortsMetabolic syndrome and risk of cancer: a systematic review and meta-analysis.Blood glucose concentration and risk of liver cancer: systematic review and meta-analysis of prospective studies.Body mass index and risk of primary liver cancer: a meta-analysis of prospective studiesDietary glycemic load, glycemic index, and carbohydrates on the risk of primary liver cancer among Chinese women and men.Proprotein convertase subtilisin/kexin type 9 deficiency reduces melanoma metastasis in liverMetabolic syndrome and hepatocellular carcinoma riskProhibitin-induced, obesity-associated insulin resistance and accompanying low-grade inflammation causes NASH and HCCHepatocellular carcinoma: epidemiology and risk factorsLiver and diabetes. A vicious circle.Primary hepatocellular carcinoma and metabolic syndrome: An update.The association between metabolic syndrome and hepatocellular carcinoma: systemic review and meta-analysis.Oncogenic mutations and dysregulated pathways in obesity-associated hepatocellular carcinoma.Characteristics of patients with liver cancer in the BioBank Japan project.Potential for statins in the chemoprevention and management of hepatocellular carcinoma.Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: a review of human studies.Residual risk of hepatocellular carcinoma after HCV eradication: more than meets the eye.Impact of metabolic syndrome on the survival of Chinese patients with resectable esophageal squamous cell carcinoma.The story of HCC in NAFLD: from epidemiology, across pathogenesis, to prevention and treatment.APSA Awardee Submission: Tumor/cancer stem cell marker doublecortin-like kinase 1 in liver diseases.Obesity and Liver Cancer.Cardio-oncology Related to Heart Failure: Common Risk Factors Between Cancer and Cardiovascular Disease.
P2860
Q26741102-494E3C0E-F39E-49DE-8E21-8392DE4CFA1AQ26741708-6915330B-C283-4BE6-A268-004864E6AF94Q26783881-611C58A4-87D0-4AF5-9A4E-1EB68A3E0F7DQ26823575-819383FC-9A68-4D94-997D-9A030750F318Q26852910-54BD08B9-8CD3-42D7-BD0F-C950D29D9C6EQ26864513-7D25E997-8E03-4C6C-859D-4B417AEECAA3Q31152938-B0092573-C6B6-427F-892D-F8D236419E41Q31170677-A2BB5B51-D107-4ECC-87D4-6DA77CC6823AQ33597307-B1FCA86C-E3A6-470A-B91A-84A7B070170DQ33798871-4A16C19B-2896-46D1-AAF7-12709EA26935Q33809722-46B8621E-771D-48D2-B434-995FA50155CDQ34571058-C63510BF-7265-460C-8605-D2561A20B625Q34681110-FF1ED07D-9806-41B5-955D-1C582A4AB46DQ34997752-EEE1E559-8DB9-48B1-A753-0EE820E2DEAEQ35059999-7C944382-89C0-4CEE-8CF2-A3BF5EB90C62Q35107146-E6B6FE11-5194-4AA8-B63B-57A8CDE6B059Q35576656-D8210FA6-6F7D-489F-AA0E-68FEC0B6440FQ35935362-44850CC8-B181-4A48-B9CC-AF7519475905Q36107648-95CF557D-34E6-44FA-8CEB-205A4D6DB2C3Q36334568-4925535A-D278-4654-91E3-51B68A815477Q36353953-3F09939B-AA58-4F14-B844-40D1679F168AQ36405672-9D7564D9-3EF4-4692-9326-1126D504CAFAQ36474916-7C08EC12-B8C9-4718-9414-CBF461EE0160Q36520700-A8AC87CB-5727-4935-9DBE-A85D1C99CB1FQ36557772-C063A610-9731-453A-B09B-94114DE54F77Q36719439-2D803B9E-A5EF-4AF8-A537-108A0822012BQ37031724-088D94C9-CB91-4324-B485-00BF4070E517Q37070333-0F7D6627-3F54-46CF-AEDD-3679BA4FD5D1Q37196508-0EF1D001-25D1-4438-9612-A4025ABE22DEQ37459930-D24DA823-8216-4E90-86BD-80FCA2AB12F1Q37497314-4EF9FE01-DC70-4782-88A7-2687CC2450C2Q37700221-BF3727A1-7C0D-47E9-B969-ED52A0873F07Q38030991-C5025110-B64B-40F9-9084-9154A8112CD6Q38313236-609BCC48-9C27-45AD-ACB8-E37DBB54E006Q38522791-F41A1F77-FFA8-44A9-8944-1CEA5A804D21Q38540337-A00246DE-7482-4721-9AB2-A767B6420209Q38645975-A58EFC8F-74CD-4495-859D-6D5A5DF8735DQ38970151-8934636C-6809-49C8-8370-9E8E39A1E091Q39026668-0E7B20C5-6C44-4452-83A9-36FDC3B8C3A5Q39171512-7F9A8B6E-DEAC-4866-91D5-93FF42C5E329
P2860
Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults.
@en
Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults.
@nl
type
label
Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults.
@en
Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults.
@nl
prefLabel
Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults.
@en
Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults.
@nl
P2093
P2860
P50
P356
P1476
Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults.
@en
P2093
Anders Engeland
Björn Lindkvist
Gabriele Nagel
Hanno Ulmer
Hans Concin
Håkan Jonsson
Jonas Manjer
Michael Edlinger
Pär Stattin
Randi Selmer
P2860
P304
P356
10.1002/IJC.26338
P577
2011-09-08T00:00:00Z